Report overview
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial ? their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
This report aims to provide a comprehensive presentation of the global market for Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trials. This report contains market size and forecasts of Clinical Trials in global, including the following market information:
Global Clinical Trials Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Clinical Trials market was valued at US$ 48020 million in 2022 and is projected to reach US$ 63030 million by 2029, at a CAGR of 4.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.
We surveyed the Clinical Trials companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clinical Trials Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Clinical Trials Market Segment Percentages, by Type, 2022 (%)
Phase I
Phase II
Phase III
Phase IV
Global Clinical Trials Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Clinical Trials Market Segment Percentages, by Application, 2022 (%)
Interventional
Observational
Expanded Access
Global Clinical Trials Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Clinical Trials Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clinical Trials revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Clinical Trials revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Quintiles IMS
Paraxel International Corporation
Charles River Laboratories
ICON plc
SGS SA
Pharmaceutical Product Development, LLC
Wuxi AppTec Inc.
PRA Health Sciences
Chiltern International Ltd.
INC Research
Outline of Major Chapters:
Chapter 1: Introduces the definition of Clinical Trials, market overview.
Chapter 2: Global Clinical Trials market size in revenue.
Chapter 3: Detailed analysis of Clinical Trials company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Clinical Trials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
